BIOQ

Bioqual, Inc. [BIOQ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

BIOQ Stock Summary

Top 10 Correlated ETFs

BIOQ

Top 10 Correlated Stocks

BIOQ

In the News

BIOQ Financial details

Company Rating
-
Market Cap
67.04M
Income
-457.7K
Revenue
61.62M
Book val./share
-
Cash/share
-
Dividend
0.5
Dividend %
0.78%
Employees
278
Optionable
No
Shortable
Yes
Earnings
19 Apr 2024
P/E
15.61
Forward P/E
-
PEG
-1.44
P/S
1.59
P/B
2.59
P/C
-
P/FCF
34.97
Quick Ratio
5.73
Current Ratio
5.85
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.51
EPS next Y
-
EPS next Q
-
EPS this Y
-84.18%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-25.67%
Revenue last 5Y
11.79%
Revenue Q/Q
1.86%
EPS Q/Q
-46.53%
-
-
-
-
SMA20
-1.09%
SMA50
-10.29%
SMA100
-11.11%
Inst Own
-
Inst Trans
-
ROA
14%
ROE
18%
ROC
0.23%
Gross Margin
24%
Oper. Margin
15%
Profit Margin
10%
Payout
15%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
59.0-82.0
52W High
-26.83%
52W Low
+1.69%
RSI
-
Rel Volume
-
Avg Volume
19
Volume
Perf Week
0%
Perf Month
-3.23%
Perf Quarter
-14.29%
Perf Half Y
-14.29%
-
-
-
-
Beta
-0.216
-
-
Volatility
0%, 0.68%
Prev Close
0%
Price
60
Change
0%

BIOQ Financial Performance

BIOQ Dividend History

BIOQ Frequently Asked Questions

What is Bioqual, Inc. stock symbol ?

Bioqual, Inc. is a US stock , located in Rockville of Md and trading under the symbol BIOQ

What is Bioqual, Inc. stock quote today ?

Bioqual, Inc. stock price is $60 today.

Is Bioqual, Inc. stock public?

Yes, Bioqual, Inc. is a publicly traded company.

Something similar

Top by Market Cap
V
FB2A.DE
AAPL
NVD.DE
GOOG
Top Correlated ETFs
BNC.TO
HAO
MOAT
GDXD
ETCG
Top Correlated Stocks
NPKYY
THYCY
TNXP
NSSC
VIRX
Similar Market Cap
APM.DE
JHPI
0I0B.L
0812.HK
MFH

Company Profile

Healthcare Medical - Diagnostics & Research
  • Volume Average 19
  • Market Capitalization 67.04M
  • Employee 278
  • CEO Dr. Mark G. Lewis Ph.D.
  • Headquarters Rockville,MD,US
  • IPO Date 2002-06-21
  • Website https://www.bioqual.com

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.